Record entry · South Korea
Samsung Biologics
Why this name is on the record
Samsung Biologics was added automatically on 5 Oct 2026 after 20 mentions across 8 sources over 13 days. 75% of that coverage came from a single subject area.
“Samsung Biologics, SK Biopharm, Hanmi Make Asia-Pacific's Top 10 Biotech Deals”
“Samsung Biologics Union Calls Three-Week Second Strike”
“KOSPI Opens Lower Despite Micron's Record Results”
“Samsung Biologics highlights faster drug manufacturing timelines at BPI Boston”
“Fierce Pharma Asia—Takeda’s R&D leadership change; Daiichi’s $1.3B court win; New Samsung Bio contract”
“Samsung Group to begin second-half 2026 open recruitment”
For developers
GET https://sigb.ai/api/registry?slug=samsung-biologics
{
"slug": "samsung-biologics",
"state": "active",
"detail": {
"state": "active",
"source": "ontology",
"label": "samsung biologics",
"promotedAt": "2026-10-05",
"category": "south_korea",
"evidence": {
"mentions": 20,
"sources": 8,
"days": 13,
"concentration": 0.75,
"standAloneShare": 0.952
}
}
}The record behind this page, as data. The live response also carries the registry date and version.
The coverage behind it
- 5 Oct 2026
Seoul Economic Daily - English Edition
Samsung Biologics, SK Biopharm, Hanmi Make Asia-Pacific's Top 10 Biotech Deals
“Samsung Biologics, SK Biopharm, Hanmi Make Asia-Pacific's Top 10 Biotech Deals”
- 2 Oct 2026
Seoul Economic Daily - English Edition
Samsung Biologics Union Calls Three-Week Second Strike
“Samsung Biologics Union Calls Three-Week Second Strike”
- 1 Oct 2026
Seoul Economic Daily - English Edition
KOSPI Opens Lower Despite Micron's Record Results
“KOSPI Opens Lower Despite Micron's Record Results”
- 28 Sept 2026
Korea Times
Samsung Biologics highlights faster drug manufacturing timelines at BPI Boston
“Samsung Biologics highlights faster drug manufacturing timelines at BPI Boston”
- 12 Sept 2026
Fierce Pharma
“Fierce Pharma Asia—Takeda’s R&D leadership change; Daiichi’s $1.3B court win; New Samsung Bio contract”
- 7 Sept 2026
Korea Times
Samsung Group to begin second-half 2026 open recruitment
“Samsung Group to begin second-half 2026 open recruitment”
No trend and no market price are shown because neither has been measured for Samsung Biologics yet. Informational only, not advice. As of 5 Oct 2026.